Date: 29th April 2024
Time: from 4:00 PM to 5:00 PM
Venue: Online
Audience: Companion segment: Veterinarians and Nurses
Price: AED 0
Please click here to register and secure your seat.
Fill out the required information, and we'll confirm your registration shortly. Thank you for your interest
About the Speakers
Dr. Yih-Shuang Lin
Chief Veterinarian
Eden Animal Hospital, Taipei, Taiwan
Yih-shuang Lin is currently a chief veterinarian at Eden Animal Hospital in Taipei city, where she focuses in the field of Nephrology and Internal Medicine. Lin received her veterinary degree from National Taiwan University (NTU), and later pursed her master’s degree at NTU with her research in Feline Morbillivirus and kidney diseases. She received advanced trainings during her internships at NTU, and Hemodialysis Academy by UC Davis. Lin had been an IRIS ambassador to Taiwan, and a speaker for the management for acute and chronic kidney diseases. She is passionate about sharing her cases and learnings of the newly discovered diagnostic tools with her peers.
Dr. Rita Chang
Senior Medical Affairs Manager, CAG
IDEXX Taiwan
Dr. Chang has a background as a clinician in exotic pet medicine, later she received her PhD working with diagnostic tests development and infectious disease studies. After her PhD, she focused on the training of clinical pathology, while remaining closely involved with the clinical side of veterinary medicine in small animals. Her unique background with training in diagnostic sciences and strong interests in the clinical perspective of disease progression has made her a very popular speaker for clinicians.
Please click here to register and secure your seat.
Fill out the required information, and we'll confirm your registration shortly. Thank you for your interest
This event is hosted in partnership with IDEXX.
Title: The Phosphorus/Calcium management in chronic kidney diseases and the utility of FGF-23 in early-stage kidney diseases.
1. Why is Phos/Ca management important for CKD patients?
2. What leads to Phos/Ca imbalance in a CKD patient?
3. How to utilize FGF-23 in the management of early-stage CKD?
4. Case studies